Enkephalin-degrading aminopeptidase in the longitudinal muscle layer of guinea pig small intestine: its properties and action on neuropeptides
- PMID: 1679058
- DOI: 10.1093/oxfordjournals.jbchem.a123409
Enkephalin-degrading aminopeptidase in the longitudinal muscle layer of guinea pig small intestine: its properties and action on neuropeptides
Abstract
A membrane-bound enkephalin-degrading aminopeptidase was purified from the longitudinal muscle layer of the guinea pig small intestine by four steps of column chromatography using L-tyrosine beta-naphthylamide. The molecular weight of the enzyme was estimated to be 105,000 by gel filtration. The maximum activity was observed between pH 6.5 and 7.0. The Km value for leucine-enkephalin was 137 microM. The aminopeptidase activity toward aminoacyl beta-naphthylamide substrates was restricted to basic, neutral, and aromatic aminoacyl derivatives. No action was detected on acidic amino acid and proline derivatives. The enzyme was potently inhibited by the aminopeptidase inhibitors actinonin, amastatin, and bestatin, and bioactive peptides such as angiotensin III, substance P, and Met-Lys-bradykinin. The enzyme activity was also inhibited by the antibody against the purified serum enkephalin-degrading aminopeptidase of guinea pig at concentrations similar to those at which activity was observed toward serum enkephalin-degrading aminopeptidase and renal aminopeptidase M. The enzyme rapidly hydrolyzed Leu-enkephalin and Met-enkephalin with the sequential removal of the N-terminal amino acid residues. The enzyme also hydrolyzed two enkephalin derivatives, angiotensin III and neurokinin A. However, neurotensin, substance P, and bradykinin were not cleaved. These properties indicated that the membrane-bound enkephalin-degrading aminopeptidase in the longitudinal muscle layer of the small intestine is similar to the serum enkephalin-degrading aminopeptidase and resembles aminopeptidase M. It is therefore suggested to play an important role in the metabolism of some bioactive peptides including enkephalin in peripheral nervous systems in vivo.
Similar articles
-
Identification and characterization of aminopeptidases from Aplysia californica.Biochem J. 1992 Sep 15;286 ( Pt 3)(Pt 3):967-75. doi: 10.1042/bj2860967. Biochem J. 1992. PMID: 1417757 Free PMC article.
-
Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.Biochim Biophys Acta. 1986 Jul 16;882(3):437-44. doi: 10.1016/0304-4165(86)90268-0. Biochim Biophys Acta. 1986. PMID: 2873842
-
Purification and characterization of an enkephalin-degrading aminopeptidase from guinea pig serum.Biochim Biophys Acta. 1984 Mar 22;798(1):8-13. doi: 10.1016/0304-4165(84)90003-5. Biochim Biophys Acta. 1984. PMID: 6367829
-
From bitter to delicious: properties and uses of microbial aminopeptidases.World J Microbiol Biotechnol. 2023 Jan 10;39(3):72. doi: 10.1007/s11274-022-03501-3. World J Microbiol Biotechnol. 2023. PMID: 36625962 Review.
-
Spinorphin as an endogenous inhibitor of enkephalin-degrading enzymes: roles in pain and inflammation.Curr Protein Pept Sci. 2002 Dec;3(6):587-99. doi: 10.2174/1389203023380404. Curr Protein Pept Sci. 2002. PMID: 12470213 Review.
Cited by
-
Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.Biochem J. 1996 Nov 1;319 ( Pt 3)(Pt 3):817-21. doi: 10.1042/bj3190817. Biochem J. 1996. PMID: 8920985 Free PMC article.
-
Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.J Neurosci. 2003 Mar 1;23(5):1847-58. doi: 10.1523/JNEUROSCI.23-05-01847.2003. J Neurosci. 2003. PMID: 12629189 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous